Carcinogenicity of Tamoxifen

This publication has 61 references indexed in Scilit:

• DNA damage as assessed by ³²P-postlabelling in three rat strains exposed to dietary tamoxifen: the relationship between cell proliferation and liver tumour formation
  Carcinogenesis: Integrative Cancer Research, 1995
• Endometrial müllerian carcinosarcoma after cessation of tamoxifen therapy for breast cancer
  International Journal of Gynecology & Obstetrics, 1995
• Tamoxifen: evidence by ³²P–postlabeling and use of metabolic inhibitors for two distinct pathways leading to mouse hepatic DNA adduct formation and identification of 4–hydroxytamoxifen as a proximate metabolite
  Carcinogenesis: Integrative Cancer Research, 1994
• Non-linearity of neoplastic conversion induced in rat liver by low exposures to diethylnitrosamine
  Carcinogenesis: Integrative Cancer Research, 1993
• A Follicular Cyst during Tamoxifen Therapy in a Premenopausal Breast Cancer Woman
  Gynecologic and Obstetric Investigation, 1993
• Tamoxifen induces hepatocellular carcinoma in rat liver: A 1-year study with two antiestrogens
  Archives of Toxicology, 1993
• Tamoxifen‐stimulated Growth of Human Endometrial Carcinoma
  Annals of the New York Academy of Sciences, 1991
• Synthetic estrogens and tamoxifen as promoters of hepatocarcinogenesis
  Preventive Medicine, 1991
• Tumor promotion as a target for estrogen/antiestrogen effects in rat hepatocarcinogenesis
  Preventive Medicine, 1991
• Induction and promotion of γ-glutamyltranspeptidase-positive foci in the liver of female rats treated with ethinyl estradiol, clomiphene, tamoxifen and their associations
  Cancer Letters, 1989